Imbruvica 140 mg

Description Of Imbruvica 140mg

Imbruvica 140mg Capsule is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat mantle cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, marginal zone lymphoma, Waldenstrom macroglobulinemia, and chronic graft-versus-host disease.

Imbruvica 140mg Chemical Name

Ibrutinib

Imbruvica 140mg Manufacturer

Janssen Pharmaceuticals

Uses of Imbruvica 140mg

Imbruvica 140mg Capsule is used in the  nursing of mantle-cell lymphoma and lifeblood cancer (Chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy or with 17p deletion.

What is Imbruvica 140mg?

Imbruvica 140mg Capsule (ibrutinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Imbruvica 140mg Capsule is used to treat certain types of non-Hodgkin lymphoma, including mantle cell lymphoma (MCL), Waldenstrom's macroglobulinemia, and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in people with or without 17p deletion.

How Imbruvica 140mg working?

Imbruvica 140mg pills is a Bruton's tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to graw . This helps to stop or slow the growth of cancer cells.

How is Imbruvica 140mg used?

Take this pills in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.

Imbruvica 140mg Indications

Take this medicine with or without food. Do not take in larger or small amounts than advised/prescribed. Your dose is likely to change during the duration of the therapy based on your clinical condition and therapeutic response. Consult the doctor if you experience any undesirable side effects.

Imbruvica 140mg Dosage

Imbruvica 140mg

Contraindication Of Imbruvica 140mg

Serious bleeding events such as intracranial bleeding (e.g., subdural hematoma), GI bleeding, hematuria, and post-procedural hemorrhage have been reported with ibrutinib therapy; some cases were fatal. Patients receiving concomitant antiplatelet or anticoagulant therapy may be at increased risk for bleeding; monitor these patients for signs of bleeding.

Adverse effects Of Imbruvica 140mg

• constipation
• diarrhea
• dizziness
• fatigue
• headache
• nausea
• rash
• sore mouth
• vomiting

Special Precautions And Related Warnings Of Imbruvica 140mg

This medication contains Imbruvica 140mg Capsule. Do not take Imbruvica 140mg Capsule if you are allergic to Imbruvica 140mg pills or any ingredients contained in this medicine.

Keep out of reach of children. In case of overdose, get health check help or contact a Poison Control Center immediately.

Before taking Imbruvica 140mg Capsule, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies.

Do not drive, use machinery, or do anything that needs alertness until you can do it secure. Limit alcoholic beverages.

Storage Conditions for Imbruvica 140mg

Store in the original container at space  temperature away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.